How Viehbacher was paid
$23.6M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Incentive | Pension | Other | Total |
|---|---|---|---|---|---|---|---|
| Christopher A. ViehbacherPresident and Chief Executive Officer | $1,727,885 | — | $18,368,875 | $3,190,875 | — | $358,369 | $23,646,004 |
| Robin C. KramerExecutive Vice President and Chief Financial Officer | $759,617 | — | $4,173,781 | $788,252 | — | $84,934 | $5,806,584 |
| Susan H. AlexanderExecutive Vice President, Chief Legal Officer | $1,028,111 | — | $5,845,129 | $1,062,219 | $37,718 | $159,340 | $8,132,517 |
| Priya A. SinghalHead of Development | $929,712 | $898 | $5,566,081 | $950,833 | — | $123,863 | $7,571,387 |
| Nicole C. MurphyHead of Pharmaceutical Operations and Technology | $909,109 | — | $5,566,081 | $977,828 | — | $122,487 | $7,575,505 |
| Michael R. McDonnellFormer Executive Vice President and Chief Financial Officer | $226,895 | — | — | — | — | $43,955 | $270,850 |
What changed and why
- $23.6MChristopher A. Viehbacher earned total compensation of $23,646,004 for 2025.
- The CEO to median employee pay ratio was estimated at 113 to 1.
- $3.3BGrowth product revenue increased 19% year-over-year to $3.3 billion in 2025.
- 67.7%Say on pay received 67.7% support at the prior annual meeting.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.